Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Cancer Center
Grant: S10 OD018223
Cancer Center
Grant: S10 RR 026825
National Institutes of Health/National Cancer Institute
Grant: K01OD026526
National Institutes of Health/National Cancer Institute
Grant: R03CA252793
National Institutes of Health/National Cancer Institute
Grant: T32CA251007
National Institutes of Health/National Cancer Institute
Grant: U01 CA224166-01
NCI
Grant: P30 CA093373
NIH HHS
Grant: T32 OD010437
NHLBI NIH HHS
Grant: R01 HL140921
NCI NIH HHS
Grant: U01 CA224166
NCI NIH HHS
Grant: R03 CA270854
National Institutes of Health
Grant: 1S10RR026825-01
Shared LSRII Cytometer Equipment Application - UC Davis Stem Cell Program
National Institutes of Health
Grant: 3P30CA093373-07S2
Cancer Center Support Grant - P30
National Institutes of Health
Grant: 1S10OD018223-01A1
UC Davis Shared Astrios Cell Sorter
National Institutes of Health
Grant: 5K01OD026526-05
Defining the role of core binding factor protein interactions in osteosarcoma
National Institutes of Health
Grant: 1U01CA224166-01
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
National Institutes of Health
Grant: 5T32CA251007-03
UC Davis Comparative Oncology Training Program
National Institutes of Health
Grant: 5R03CA252793-02
Gene Expression Analysis of Dog Natural Killer Cells as Immunotherapy Target
UC
UC Davis Veterinary Center for Clinical Trials and the Clinical Trials Residents
University of California Davis Flow Cytometry Shared Resource Laboratory
UC Davis Center for Companion Animal Health
Comprehensive Cancer Center
FWCI
2.33
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals